Hämmerle, Peter
Aeschbacher, Stefanie
Springer, Anne
Eken, Ceylan
Coslovsky, Michael
Dutilh, Gilles
Moschovitis, Giorgio
Rodondi, Nicolas
Chocano, Patricia
Conen, David
Osswald, Stefan
Kühne, Michael
Zuern, Christine S. http://orcid.org/0000-0001-6625-284X
Clinical trials referenced in this document:
Documents that mention this clinical trial
Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation
https://doi.org/10.1007/s00392-022-02015-0
Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation
https://doi.org/10.1136/heartjnl-2022-321300
Cardiac autonomic function and cognitive performance in patients with atrial fibrillation
https://doi.org/10.1007/s00392-021-01900-4
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (33CS30_1148474, 33CS30_177520)
Universität Basel
Foundation for Cardiovascular Research
Universität Basel
Article History
Received: 13 February 2021
Accepted: 16 June 2021
First Online: 22 June 2021
Declarations
:
: DC holds a McMaster University Department of Medicine Mid-Career Research Award. CMZ reports honoraria from Vifor Pharma and Novartis. GM has received consultant fees for taking part to advisory boards from Novartis, Boehringer Ingelheim, Bayer and Astra Zeneca, all outside of the submitted work. MK has received grants from the Swiss National Science Foundation, the Swiss Heart Foundation, Daiichi-Sankyo, Bayer, and Pfizer-BMS and lecture/consulting fees from Daiichi-Sankyo, Boehringer Ingelheim, Bayer, Pfizer-BMS, AstraZeneca, Sanofi-Aventis, Novartis, MSD, Medtronic, Boston Scientific, St. Jude Medical, Biotronik, Sorin, Zoll and Biosense Webster. NR has received a grant from the Swiss Heart Foundation. The remaining co-authors do not report conflict of interest.